Coherus BioSciences Stock Price

-0.57 (-4.73%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,215,577
Bid Price 11.27
Ask Price 12.29
News -
Day High 12.13


52 Week Range


Day Low 11.44
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Coherus BioSciences Inc CHRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.57 -4.73% 11.47 16:00:29
Open Price Low Price High Price Close Price Prev Close
12.05 11.44 12.13 11.47 12.04
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,126 1,215,577 $ 11.74 $ 14,275,165 - 11.44 - 22.2166
Last Trade Time Type Quantity Stock Price Currency
16:14:35 average 50,600 $ 11.50 USD


Draw Mode:

Coherus BioSciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 880.73M 76.79M 54.48M $ 475.82M $ -453.65M 1.61 -3.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -13.51k 1.40%

more financials information »

Coherus BioSciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CHRS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week13.0813.2611.4412.48976,527-1.61-12.31%
1 Month17.0317.1911.4413.90874,630-5.56-32.65%
3 Months17.7119.3211.4416.24748,971-6.24-35.23%
6 Months12.8219.3211.4416.04696,487-1.35-10.53%
1 Year20.64522.216611.4415.72855,863-9.18-44.44%
3 Years12.2023.9110.861617.311,001,646-0.73-5.98%
5 Years27.5028.858.0516.50864,643-16.03-58.29%

Coherus BioSciences Description

Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.

Your Recent History
Coherus Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.